Young sparks light up pharmacy future

The future of pharmacy is bright, engaged and passionate, the search for the latest PSA MIMS Intern Pharmacist of the Year has revealed. Judges were...

The impact of air pollution

Air pollution is making us sick according to local and global research, including a study linking exposure to air pollution with subsequent acute cardiac...

Caring for our elders

This Royal Commission is an opportunity to improve how we care for our elderly, and release the chains holding pharmacists back from preventing inappropriate...

Complementary medicines during cold and flu season

As cold and flu season reaches fever pitch, the demand for complementary medicines to help prevent and manage colds and influenza is increasing. A...

Pharmacy Board’s measured step on prescribing

The Pharmacy Board of Australia has recognised that pharmacists should be able to prescribe under two monitored models of prescribing, in a move welcomed...

Efficacy of antiplatelets in deep venous thrombosis

Venous thromboembolism (VTE) is the third most common cardiovascular disease in the world. Every year, 30,000 people in Australia develop VTE, at a cost of $1.72 billion to the Australian health system.